Nobuyuki Shibusawa
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nobuyuki Shibusawa has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Hitoshi Okazawa
Department of Neuropathology, Medical Research Institute, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo 113-8510, Japan
1 shared publication Izumi Takeyoshi
Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Japan
1 shared publicationJun Horiguchi
Department of Thoracic and Visceral Organ Surgery, Gunma University Graduate School of Medicine, Japan
1 shared publicationKazuhiko Tagawa
Department of Neuropathology, Medical Research Institute and Center for Brain Integration Research, Tokyo Medical and Dental University , Tokyo, Japan
1 shared publication- Kazutaka Tsujimoto
Department of Molecular Endocrinology and Metabolism, Graduate School of Medical and Dental Sciences, Institute of Science Tokyo, Tokyo, Japan
1 shared publication Kenichi Kawahori
Department of Molecular Endocrinology and Metabolism, Tokyo Medical and Dental University , Tokyo, Japan
1 shared publication
Latest Publications
- 1 March 2018
- Published by SAGE Publications in Thyroid®
- Vol. 28 (3) , 395-406
Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring
Background: Thyroid hormones are essential for normal development of the central nervous system (CNS). Experimental rodents have shown that even a subtle thyroid hormone insufficiency in circulating maternal thyroid hormones during pregnancy may adversely affect neurodevelopment in offspring, resulting in irreversible cognitive deficits. This may be due to the persistent reduced expression of the hippocampal brain-derived neurotrophic factor gene (Bdnf), which plays a crucial role in CNS development. However, the underlying molecular mechanisms remain unclear. Methods: We administered 0.025% (w/v) thiamazole (MMI) to dams from two weeks prior to conception until delivery and succeeded in inducing mild maternal hypothyroxinemia during pregnancy. We measured serum thyroid hormone and thyrotropin (thyroid-stimulating hormone: TSH) levels of the offspring derived from dams with mild maternal hypothyroxinemia, which were referred to as M offspring and the control offspring (C offspring). At 70 days after birth (d70), we performed several behavior tests to the offspring. We also evaluated gene expression and DNA methylation status in the promoter region of Bdnf exon IV, which is largely responsible for neural activity-dependent BDNF gene expression, in the hippocampus of the offspring at d28 and d70. Results: We found no significant differences in serum thyroid hormone or TSH levels between M and C offspring at d28 and d70. M offspring showed an impaired learning capacity in the behavior tests. Hippocampal steady-state Bdnf exon IV expression was significantly weaker in M offspring than in C offspring at d28. At d70, hippocampal Bdnf exon IV expression at the basal level was comparable between M and C offspring, however it was significantly weaker in M offspring than in C offspring after the behavior tests. We also found persistent DNA hypermethylation in the promoter region of Bdnf exon IV in the hippocampus of M offspring compared to that of C offspring, which may cause the attenuation of Bdnf exon IV expression in M offspring. Conclusions: Mild maternal hypothyroxinemia induces persistent DNA hypermethylation in Bdnf exon IV in offspring as epigenetic memory, which may result in long-term cognitive disorders.
- 1 March 2018
- Published by SAGE Publications in Thyroid®
- Vol. 28 (3) , 395-406
Mild Maternal Hypothyroxinemia During Pregnancy Induces Persistent DNA Hypermethylation in the Hippocampal Brain-Derived Neurotrophic Factor Gene in Mouse Offspring
Background: Thyroid hormones are essential for normal development of the central nervous system (CNS). Experimental rodents have shown that even a subtle thyroid hormone insufficiency in circulating maternal thyroid hormones during pregnancy may adversely affect neurodevelopment in offspring, resulting in irreversible cognitive deficits. This may be due to the persistent reduced expression of the hippocampal brain-derived neurotrophic factor gene (Bdnf), which plays a crucial role in CNS development. However, the underlying molecular mechanisms remain unclear. Methods: We administered 0.025% (w/v) thiamazole (MMI) to dams from two weeks prior to conception until delivery and succeeded in inducing mild maternal hypothyroxinemia during pregnancy. We measured serum thyroid hormone and thyrotropin (thyroid-stimulating hormone: TSH) levels of the offspring derived from dams with mild maternal hypothyroxinemia, which were referred to as M offspring and the control offspring (C offspring). At 70 days after birth (d70), we performed several behavior tests to the offspring. We also evaluated gene expression and DNA methylation status in the promoter region of Bdnf exon IV, which is largely responsible for neural activity-dependent BDNF gene expression, in the hippocampus of the offspring at d28 and d70. Results: We found no significant differences in serum thyroid hormone or TSH levels between M and C offspring at d28 and d70. M offspring showed an impaired learning capacity in the behavior tests. Hippocampal steady-state Bdnf exon IV expression was significantly weaker in M offspring than in C offspring at d28. At d70, hippocampal Bdnf exon IV expression at the basal level was comparable between M and C offspring, however it was significantly weaker in M offspring than in C offspring after the behavior tests. We also found persistent DNA hypermethylation in the promoter region of Bdnf exon IV in the hippocampus of M offspring compared to that of C offspring, which may cause the attenuation of Bdnf exon IV expression in M offspring. Conclusions: Mild maternal hypothyroxinemia induces persistent DNA hypermethylation in Bdnf exon IV in offspring as epigenetic memory, which may result in long-term cognitive disorders.
- 1 January 2013
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 52 (10) , 1067-1071
Dilated Cardiomyopathy as a Presenting Feature of Cushing's Syndrome
Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome.
- 1 January 2013
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 52 (10) , 1067-1071
Dilated Cardiomyopathy as a Presenting Feature of Cushing's Syndrome
Cardiovascular complications, including cardiomegaly, myocardial ischemia and left ventricular hypertrophy, are some of the major determinants of the mortality rate in patients with Cushing's syndrome. We herein report the case of a patient with Cushing's syndrome caused by an adrenal adenoma who presented with congestive heart failure secondary to dilated cardiomyopathy. Follow-up echocardiography showed a marked improvement in the left ventricular cardiac function, and the plasma B-type natriuretic peptide (BNP) levels regressed after successful treatment. "Reversible" dilated cardiomyopathy is rarely associated with Cushing's syndrome; however, it should be recognized. Administering appropriate treatment in a timely manner can reverse this cardiomyopathy along with the other symptoms of Cushing's syndrome.